Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering.IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an underwritten…
IDEAYA Biosciences’ $80 Million Common Stock Offering
